Shares of ValiRx plc (LON:VAL – Get Free Report) were up 22.8% on Wednesday . The stock traded as high as GBX 0.18 and last traded at GBX 0.18. Approximately 33,947,781 shares traded hands during mid-day trading, an increase of 221% from the average daily volume of 10,563,343 shares. The stock had previously closed at GBX 0.14.
ValiRx Stock Up 22.8%
The stock has a 50-day moving average price of GBX 0.19 and a 200-day moving average price of GBX 0.28. The company has a debt-to-equity ratio of 0.05, a current ratio of 4.62 and a quick ratio of 1.27. The company has a market capitalization of £2.35 million, a P/E ratio of -0.33 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last released its earnings results on Monday, June 22nd. The company reported GBX (0.54) earnings per share for the quarter. ValiRx had a negative net margin of 7,115.36% and a negative return on equity of 70.79%. The firm had revenue of GBX 3 million for the quarter. On average, research analysts predict that ValiRx plc will post -1.74 EPS for the current fiscal year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
See Also
- Five stocks we like better than ValiRx
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
- 2 Quantum Stocks That Could Challenge IonQ’s Leadership
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
